Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Groner, B' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 106 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Uherek, C; Groner, B; Wels, W
      Chimeric antigen receptors for the retargeting of cytotoxic effector cells

      JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH
    2. Beisenherz-Huss, C; Mundt, M; Herrala, A; Vihko, P; Schubert, A; Groner, B
      Specific DNA binding and transactivation potential of recombinant, purified Stat5

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    3. Schmidt, M; McWatters, A; White, RA; Groner, B; Wels, W; Fan, Z; Bast, RC
      Synergistic interaction between an anti-p185(HER-2) pseudomonas exotoxin fusion protein [scFv(FRP5)-ETA] and ionizing radiation for inhibiting growthof ovarian cancer cells that overexpress HER-2

      GYNECOLOGIC ONCOLOGY
    4. Gowri, PM; Ganguly, TC; Cao, JS; Devalaraja, MN; Groner, B; Vore, M
      Conversion of threonine 757 to valine enhances stat5a transactivation potential

      JOURNAL OF BIOLOGICAL CHEMISTRY
    5. Groner, B; Hennighausen, L
      Linear and cooperative signaling: roles for Stat proteins in the regulation of cell survival and apoptosis in the mammary epithelium

      BREAST CANCER RESEARCH
    6. Groner, B; Fritsche, M; Stocklin, E; Berchtold, S; Merkle, C; Moriggl, R; Pfitzner, E
      Regulation of the trans-activation potential of STAT5 through its DNA-binding activity and interactions with heterologous transcription factors

      GROWTH HORMONE & IGF RESEARCH
    7. Aittomaki, S; Pesu, M; Groner, B; Janne, OA; Palvimo, JJ; Silvennoinen, O
      Cooperation among Stat1, glucocorticoid receptor, and PU.1 in transcriptional activation of the high-affinity Fc gamma receptor I in monocytes

      JOURNAL OF IMMUNOLOGY
    8. Beuvink, I; Hess, D; Flotow, H; Hofsteenge, J; Groner, B; Hynes, NE
      Stat5a serine phosphorylation - Serine 779 is constitutively phosphorylated in the mammary gland, and serine 725 phosphorylation influences prolactin-stimulated in vitro DNA binding activity

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Azemar, M; Schmidt, M; Arlt, F; Kennel, P; Brandt, B; Papadimitriou, A; Groner, B; Wels, W
      Recombinant antibody toxins specific for ERBB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumorregression in vivo

      INTERNATIONAL JOURNAL OF CANCER
    10. Demoulin, JB; Uyttenhove, C; Lejeune, D; Mui, A; Groner, B; Renauld, JC
      STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells

      CANCER RESEARCH
    11. Maurer-Gebhard, M; Azemar, M; Altenschmidt, U; Humar, M; Groner, B
      Direction of the recognition specificity of cytotoxic T cells toward tumorcells by transduced, chimeric T-cell receptor genes

      OVARIAN CANCER: METHODS AND PROTOCOLS
    12. Stoecklin, E; Wissler, M; Schaetzle, D; Pfitzner, E; Groner, B
      Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family

      JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
    13. Schmidt, M; Maurer-Gebhard, M; Groner, B; Kohler, G; Brochmann-Santos, G; Wels, W
      Suppression of metastasis formation by a recombinant single chain antibody-toxin targeted to full-length and oncogenic variant EGF receptors

      ONCOGENE
    14. Werkmeister, R; Fillies, T; Brandt, B; Groner, B; Wels, W; Joos, U
      Chemosensitivity testing of oral cancer cells treated with a p185(neu)-specific agent

      EUROPEAN JOURNAL OF ORAL SCIENCES
    15. Feltus, FA; Groner, B; Melner, MH
      Stat5-mediated regulation of the human type II 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase gene: Activation by prolactin

      MOLECULAR ENDOCRINOLOGY
    16. Gingras, S; Moriggl, R; Groner, B; Simard, J
      Induction of 3 beta-hydroxysteroid dehydrogenase/Delta(5)-Delta(4) isomerase type 1 gene transcription in human breast cancer cell lines and in normal mammary epithelial cells by interleukin-4 and interleukin-13

      MOLECULAR ENDOCRINOLOGY
    17. Gingras, S; Simard, J; Groner, B; Pfitzner, E
      P300/CBP is required for transcriptional induction by interleukin-4 and interacts with Stat6

      NUCLEIC ACIDS RESEARCH
    18. Maurer-Gebhard, M; Schmidt, M; Azemar, M; Stocklin, E; Wels, W; Groner, B
      A novel animal model for the evaluation of the efficacy of drugs directed against the ErbB2 receptor on metastasis formation

      HYBRIDOMA
    19. Gerstmayer, B; Groner, B; Wels, W; Schnierle, BS
      Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles

      JOURNAL OF VIROLOGICAL METHODS
    20. Hohne, M; Thaler, S; Dudda, JC; Groner, B; Schnierle, BS
      Truncation of the human immunodeficiency virus-type-2 envelope glycoprotein allows efficient pseudotyping of murine leukemia virus retroviral vector particles

      VIROLOGY
    21. Demoulin, JB; Van Roost, E; Stevens, M; Groner, B; Renauld, JC
      Distinct roles for STAT1, STAT3, and STAT5 in differentiation gene induction and apoptosis inhibition by interleukin-9

      JOURNAL OF BIOLOGICAL CHEMISTRY
    22. Wei, WZ; Shi, WP; Galy, A; Lichlyter, D; Hernandez, S; Groner, B; Heilbrun, L; Jones, RF
      Protection against mammary tumor growth by vaccination with full-length, modified human ErbB-2 DNA

      INTERNATIONAL JOURNAL OF CANCER
    23. Storz, P; Doppler, H; Horn-Muller, J; Groner, B; Pfizenmaier, K; Muller, G
      A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression

      ANALYTICAL BIOCHEMISTRY
    24. Merkle, C; Fritsche, M; Mundt, M; Jahne, R; Groner, B
      Transcriptional regulation and induction of apoptosis: implications for the use of monomeric p53 variants in gene therapy

      GENE THERAPY
    25. BERCHTOLD S; VOLAREVIC S; MORIGGL R; MERCEP M; GRONER B
      DOMINANT-NEGATIVE VARIANTS OF THE SHP-2 TYROSINE PHOSPHATASE INHIBIT PROLACTIN ACTIVATION OF JAK2 (JANUS-KINASE-2) AND INDUCTION OF STAT5 (SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION-5)-DEPENDENT TRANSCRIPTION

      Molecular endocrinology
    26. PFITZNER E; JAHNE R; WISSLER M; STOECKLIN E; GRONER B
      P300 CREB-BINDING PROTEIN ENHANCES THE PROLACTIN-MEDIATED TRANSCRIPTIONAL INDUCTION THROUGH DIRECT INTERACTION WITH THE TRANSACTIVATION DOMAIN OF STAT5, BUT DOES NOT PARTICIPATE IN THE STAT5-MEDIATED SUPPRESSION OF THE GLUCOCORTICOID RESPONSE/

      Molecular endocrinology
    27. FRITSCHE M; MUNDT M; MERKLE C; JAHNE R; GRONER B
      P53 SUPPRESSES CYTOKINE-INDUCED, STAT5 MEDIATED ACTIVATION OF TRANSCRIPTION

      Molecular and cellular endocrinology
    28. GOWRI PM; GANGULY TC; GRONER B; VORE M
      THREONINE-757 OF SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION-5(THR-STAT5) REGULATES NA+ TAUROCHOLATE COTRANSPORTER POLYPEPTIDE (NTCP) TRANSACTIVATION POTENTIAL/

      Hepatology
    29. CELLA N; GRONER B; HYNES NE
      CHARACTERIZATION OF STAT5A AND STAT5B HOMODIMERS AND HETERODIMERS ANDTHEIR ASSOCIATION WITH THE GLUCOCORTIOCOID RECEPTOR IN MAMMARY CELLS

      Molecular and cellular biology
    30. PIEKORZ RP; RINKE R; GOUILLEUX F; NEUMANN B; GRONER B; HOCKE GM
      MODULATION OF THE ACTIVATION STATUS OF STAT5A DURING LIF-INDUCED DIFFERENTIATION OF M1 MYELOID-LEUKEMIA CELLS

      Biochimica et biophysica acta. Molecular cell research
    31. BECKER S; GRONER B; MULLER CW
      3-DIMENSIONAL STRUCTURE OF THE STAT3-BETA HOMODIMER BOUND TO DNA

      Nature
    32. MORIGGL R; KRISTOFIC C; KINZEL B; VOLAREVIC S; GRONER B; BRINKMANN V
      ACTIVATION OF STAT PROTEINS AND CYTOKINE GENES IN HUMAN TH1 AND TH2 CELLS GENERATED IN THE ABSENCE OF IL-12 AND IL-4

      The Journal of immunology
    33. LISCHKE A; MORIGGL R; BRANDLEIN S; BERCHTOLD S; KAMMER W; SEBALD W; GRONER B; LIU XW; HENNIGHAUSEN L; FRIEDRICH K
      THE INTERLEUKIN-4 RECEPTOR ACTIVATES STAT5 BY A MECHANISM THAT RELIESUPON COMMON GAMMA-CHAIN

      The Journal of biological chemistry
    34. BARAHMANDPOUR F; MEINKE A; GRONER B; DECKER T
      JAK2-STAT5 INTERACTIONS ANALYZED IN YEAST

      The Journal of biological chemistry
    35. Becker, S; Corthals, GL; Aebersold, R; Groner, B; Muller, CW
      Expression of a tyrosine phosphorylated, DNA binding Stat3 beta dimer in bacteria

      FEBS LETTERS
    36. MORIGGL R; ERHARDT I; KAMMER W; BERCHTOLD S; SCHNARR B; LISCHKE A; GRONER B; FRIEDRICH K
      ACTIVATION OF STAT6 IS NOT DEPENDENT ON PHOSPHOTYROSINE-MEDIATED DOCKING TO THE INTERLEUKIN-4 RECEPTOR AND CAN BE BLOCKED BY DOMINANT-NEGATIVE MUTANTS OF BOTH RECEPTOR SUBUNITS

      European journal of biochemistry
    37. MAURERGEBHARD M; SCHMIDT M; AZEMAR M; ALTENSCHMIDT U; STOCKLIN E; WELS W; GRONER B
      SYSTEMIC TREATMENT WITH A RECOMBINANT ERBB-2 RECEPTOR-SPECIFIC TUMOR TOXIN EFFICIENTLY REDUCES PULMONARY METASTASES IN MICE INJECTED WITH GENETICALLY-MODIFIED CARCINOMA-CELLS

      Cancer research
    38. SPYRIDONIDIS A; SCHMIDT M; BERNHARDT W; PAPADIMITRIOU A; AZEMAR M; WELS W; GRONER B; HENSCHLER R
      PURGING OF MAMMARY-CARCINOMA CELLS DURING EX-VIVO CULTURE OF CD34(+) HEMATOPOIETIC PROGENITOR CELLS WITH RECOMBINANT IMMUNOTOXINS

      Blood
    39. SELIVANOVA G; IOTSOVA V; OKAN I; FRITSCHE M; STROM M; GRONER B; GRAFSTROM RC; WIMAN KG
      RESTORATION OF THE GROWTH SUPPRESSION FUNCTION OF MUTANT P53 BY A SYNTHETIC PEPTIDE DERIVED FROM THE P53 C-TERMINAL DOMAIN

      Nature medicine
    40. BRENNAN P; BABBAGE JW; BURGERING BMT; GRONER B; REIF K; CANTRELL DA
      PHOSPHATIDYLINOSITOL 3-KINASE COUPLES THE INTERLEUKIN-2 RECEPTOR TO THE CELL-CYCLE REGULATOR E2F

      Immunity
    41. GRONER B; KLUNDT E; ALTENSCHMIDT U
      CYTOTOXIC T-CELLS WITH GRAFTED, TUMOR-SPECIFIC RECOGNITION FUNCTIONS

      European journal of cancer
    42. HANSEN JA; HANSEN LH; WANG X; KOPCHICK JJ; GOUILLEUX F; GRONER B; NIELSEN JH; MOLDRUP A; GALSGAARD ED; BILLESTRUP N
      THE ROLE OF GH RECEPTOR TYROSINE PHOSPHORYLATION IN STAT5 ACTIVATION

      Journal of molecular endocrinology
    43. MUNDT M; HUPP T; FRITSCHE M; MERKLE C; HANSEN S; LANE D; GRONER B
      PROTEIN INTERACTIONS AT THE CARBOXYL-TERMINUS OF P53 RESULT IN THE INDUCTION OF ITS IN-VITRO TRANSACTIVATION POTENTIAL

      Oncogene
    44. ALTENSCHMIDT U; MORITZ D; GRONER B
      SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN GENE-THERAPY

      Journal of molecular medicine
    45. WICK B; GRONER B
      EVALUATION OF CELL-SURFACE ANTIGENS AS POTENTIAL TARGETS FOR RECOMBINANT TUMOR TOXINS

      Cancer letters
    46. WOOD TJJ; SLIVA D; LOBIE PE; GOULLIEUX F; MUI AL; GRONER B; NORSTEDT G; HALDOSEN LA
      SPECIFICITY OF TRANSCRIPTION ENHANCEMENT VIA THE STAT RESPONSIVE ELEMENT IN THE SERINE-PROTEASE INHIBITOR-2.1 PROMOTER

      Molecular and cellular endocrinology
    47. MORIGGL R; BERCHTOLD S; FRIEDRICH K; STANDKE GJR; KAMMER W; HEIM M; WISSLER M; STOCKLIN E; GOUILLEUX F; GRONER B
      COMPARISON OF THE TRANSACTIVATION DOMAINS OF STAT5 AND STAT6 IN LYMPHOID-CELLS AND MAMMARY EPITHELIAL-CELLS

      Molecular and cellular biology
    48. STOECKLIN E; WISSLER M; MORIGGL R; GRONER B
      SPECIFIC DNA-BINDING OF STAT5, BUT NOT OF GLUCOCORTICOID RECEPTOR, ISREQUIRED FOR THEIR FUNCTIONAL COOPERATION IN THE REGULATION OF GENE-TRANSCRIPTION

      Molecular and cellular biology
    49. SCHNIERLE BS; STITZ J; BOSCH V; NOCKEN F; MERGETMILLITZER H; ENGELSTADTER M; KURTH R; GRONER B; CICHUTEK K
      PSEUDOTYPING OF MURINE LEUKEMIA-VIRUS WITH THE ENVELOPE GLYCOPROTEINSOF HIV GENERATES A RETROVIRAL VECTOR WITH SPECIFICITY OF INFECTION FOR CD4-EXPRESSING CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    50. ALTENSCHMIDT U; KLUNDT E; GRONER B
      ADOPTIVE TRANSFER OF IN VITRO-TARGETED, ACTIVATED T-LYMPHOCYTES RESULTS IN TOTAL TUMOR-REGRESSION

      The Journal of immunology
    51. BERCHTOLD S; MORIGGL R; GOUILLEUX F; SILVENNOINEN O; BEISENHERZ C; PFITZNER E; WISSLER M; STOCKLIN E; GRONER B
      CYTOKINE RECEPTOR-INDEPENDENT, CONSTITUTIVELY ACTIVE VARIANTS OF STAT5

      The Journal of biological chemistry
    52. ALTENSCHMIDT U; SCHMIDT M; GRONER B; WELS W
      TARGETED THERAPY OF SCHWANNOMA CELLS IN IMMUNOCOMPETENT RATS WITH AN ERBB2-SPECIFIC ANTIBODY-TOXIN

      International journal of cancer
    53. GRONER B; WICK B; JESCHKE M; FIEBIG HH; DENGLER W; RUNAU T; MIHATSCH M; KAHL R; SCHMIDT M; WELS W; STOCKLIN E
      INTRA-TUMORAL APPLICATION OF A HEREGULIN-EXOTOXIN-A FUSION PROTEIN CAUSES RAPID TUMOR-REGRESSION WITHOUT ADVERSE SYSTEMIC OR LOCAL-EFFECTS

      International journal of cancer
    54. ALTENSCHMIDT U; KAHL R; KLUNDT E; STOCKLIN E; MIHATSCH M; WEINDEL K; GRONER B
      SCHWANNOMA CELLS INDUCE A TUMOR-CELL-SPECIFIC CYTOTOXIC-T-CELL RESPONSE UPON TRANSPLANTATION INTO SYNGENEIC RATS BUT ESCAPE ELIMINATION THROUGH THE SECRETION OF IMMUNOSUPPRESIVE FACTORS

      International journal of cancer
    55. GALY A; HE Q; FERLAZZO G; KLEIN J; GRONER B; WEI WZ
      GENERATION OF IMMUNOGENIC DENDRITIC CELLS THAT ARE GENE-MODIFIED TO PRESENT THE ERBB2 ANTIGEN

      Blood
    56. FELTUS A; DONALDSON J; GRONER B; MELNER MH
      PROLACTIN STIMULATION OF THE HUMAN TYPE-II 3-BETA-HYDROXYSTEROID DEHYDROGENASE PROMOTER - MEDIATION OF A HIGHLY ROBUST RESPONSE BY THE TYROSINE-PHOSPHORYLATED TRANSCRIPTION FACTOR STAT-5

      Biology of reproduction
    57. ALTENSCHMIDT U; KAHL R; MORITZ D; SCHNIERLE BS; GERSTMAYER B; WELS W; GRONER B
      CYTOLYSIS OF TUMOR-CELLS EXPRESSING THE NEU ERBB-2, ERBB-3, AND ERBB-4 RECEPTORS BY GENETICALLY TARGETED NAIVE T-LYMPHOCYTES/

      Clinical cancer research
    58. SCHNIERLE BS; MORITZ D; JESCHKE M; GRONER B
      EXPRESSION OF CHIMERIC ENVELOPE PROTEINS IN HELPER-CELL LINES AND INTEGRATION INTO MOLONEY MURINE LEUKEMIA-VIRUS PARTICLES

      Gene therapy
    59. SCHNIERLE BS; GRONER B
      RETROVIRAL TARGETED DELIVERY

      Gene therapy
    60. MORIGGL R; GOUILLEUXGRUART V; JAHNE R; BERCHTOLD S; GARTMANN C; LIU XW; HENNIGHAUSEN L; SOTIROPOULOS A; GRONER B; GOUILLEUX F
      DELETION OF THE CARBOXYL-TERMINAL TRANSACTIVATION DOMAIN OF MGF-STAT5RESULTS IN SUSTAINED DNA-BINDING AND A DOMINANT-NEGATIVE PHENOTYPE

      Molecular and cellular biology
    61. GOBERT S; CHRETIEN S; GOUILLEUX F; MULLER O; PALLARD C; DUSANTERFOURT I; GRONER B; LACOMBE C; GISSELBRECHT S; MAYEUX P
      IDENTIFICATION OF TYROSINE RESIDUES WITHIN THE INTRACELLULAR DOMAIN OF THE ERYTHROPOIETIN RECEPTOR CRUCIAL FOR STAT5 ACTIVATION

      EMBO journal
    62. STOCKLIN E; WISSLER M; GOUILLEUX F; GRONER B
      FUNCTIONAL INTERACTIONS BETWEEN STAT5 AND THE GLUCOCORTICOID RECEPTOR

      Nature
    63. WARTMANN M; CELLA N; HOFER P; GRONER B; LIU XW; HENNIGHAUSEN L; HYNES NE
      LACTOGENIC HORMONE ACTIVATION OF STAT5 AND TRANSCRIPTION OF THE BETA-CASEIN GENE IN MAMMARY EPITHELIAL-CELLS IS INDEPENDENT OF P42 ERK2 MITOGEN-ACTIVATED PROTEIN-KINASE ACTIVITY

      The Journal of biological chemistry
    64. KAMMER W; LISCHKE A; MORIGGL R; GRONER B; ZIEMIECKI A; GURNIAK CB; BERG LJ; FRIEDRICH K
      HOMODIMERIZATION OF INTERLEUKIN-4 RECEPTOR-ALPHA CHAIN CAN INDUCE INTRACELLULAR SIGNALING

      The Journal of biological chemistry
    65. STANCATO LF; SILVERSTEIN AM; GITLER C; GRONER B; PRATT WB
      USE OF THE THIOL-SPECIFIC DERIVATIZING AGENT N-IODOACETYL-3[I-125]IODOTYROSINE TO DEMONSTRATE CONFORMATIONAL DIFFERENCES BETWEEN THE UNBOUND AND HSP90-BOUND GLUCOCORTICOID RECEPTOR HORMONE-BINDING DOMAIN

      The Journal of biological chemistry
    66. HAN YL; LEAMAN DW; WATLING D; ROGERS NC; GRONER B; KERR IM; WOOD WI; STARK GR
      PARTICIPATION OF JAK AND STAT PROTEINS IN GROWTH HORMONE-INDUCED SIGNALING

      The Journal of biological chemistry
    67. HEKELE A; DALL P; MORITZ D; WELS W; GRONER B; HERRLICH P; PONTA H
      GROWTH-RETARDATION OF TUMORS BY ADOPTIVE TRANSFER OF CYTOTOXIC T-LYMPHOCYTES REPROGRAMMED BY CD44V6-SPECIFIC SCFV-ZETA-CHIMERA

      International journal of cancer
    68. SCHMIDT M; HYNES NE; GRONER B; WELS W
      A BIVALENT SINGLE-CHAIN ANTIBODY TOXIN SPECIFIC FOR ERBB-2 AND THE EGF RECEPTOR

      International journal of cancer
    69. WEHINGER J; GOUILLEUX F; GRONER B; FINKE J; MERTELSMANN R; WEBERNORDT RM
      IL-10 INDUCES DNA-BINDING ACTIVITY OF 3 STAT PROTEINS (STAT1, STAT3, AND STAT5) AND THEIR DISTINCT COMBINATORIAL ASSEMBLY IN THE PROMOTERS OF SELECTED GENES

      FEBS letters
    70. GOUILLEUXGRUART V; GOUILLEUX F; DESAINT C; CLAISSE JF; CAPIOD JC; DELOBEL J; WEBERNORDT R; DUSANTERFOURT I; DREYFUS F; GRONER B; PRIN L
      STAT-RELATED TRANSCRIPTION FACTORS ARE CONSTITUTIVELY ACTIVATED IN PERIPHERAL-BLOOD CELLS FROM ACUTE-LEUKEMIA PATIENTS

      Blood
    71. HYNES NE; GRONER B
      A TARGET FOR TUMOR-DIRECTED THERAPY

      Nature medicine
    72. MORITZ D; GRONER B
      A SPACER REGION BETWEEN THE SINGLE-CHAIN ANTIBODY-CHAIN AND THE CD3 ZETA-CHAIN DOMAIN OF CHIMERIC T-CELL RECEPTOR COMPONENTS IS REQUIRED FOR EFFICIENT LIGAND-BINDING AND SIGNALING ACTIVITY

      Gene therapy
    73. SCHMIDT M; HYNES NE; GRONER B; WELS W
      RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR THE EGF RECEPTOR AND ERBB-2

      European journal of cancer
    74. GRONER B; GOUILLEUX F
      PROLACTIN-MEDIATED GENE ACTIVATION IN MAMMARY EPITHELIAL CELLS

      Current opinion in genetics & development
    75. MARTE BM; JESCHKE M; GRAUSPORTA D; TAVERNA D; HOFER P; GRONER B; YARDEN Y; HYNES NE
      NEU DIFFERENTIATION FACTOR HEREGULIN MODULATES GROWTH AND DIFFERENTIATION OF HC11 MAMMARY EPITHELIAL-CELLS

      Molecular endocrinology
    76. STOCKLIN EJ; WISSLER M; WELS W; GRONER B
      INTRACELLULAR EXPRESSION OF A SINGLE-CHAIN DERIVATIVE OF A C-RAF SPECIFIC MONOCLONAL-ANTIBODY

      Journal of cellular biochemistry
    77. GRONER B; DENGLER W; WELS W; IMBER R; STOCKLIN E; JESCHKE M
      TARGETED INHIBITION OF TUMOR-CELL GROWTH BY RECOMBINANT HEREGULIN-TOXIN FUSION PROTEINS

      Journal of cellular biochemistry
    78. WELS W; MORITZ D; SCHMIDT M; JESCHKE M; HYNES NE; GRONER B
      BIOTECHNOLOGICAL AND GENE THERAPEUTIC STRATEGIES IN CANCER-TREATMENT

      Gene
    79. GOUILLEUX F; PALLARD C; DUSANTERFOURT I; WAKAO H; HALDOSEN LA; NORSTEDT G; LEVY D; GRONER B
      PROLACTIN, GROWTH-HORMONE, ERYTHROPOIETIN AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR INDUCE MGF-STAT5 DNA-BINDING ACTIVITY

      EMBO journal
    80. WAKAO H; GOUILLEUX F; GRONER B
      MAMMARY-GLAND FACTOR (MGF) IS A NOVEL MEMBER OF THE CYTOKINE REGULATED TRANSCRIPTION FACTOR GENE FAMILY AND CONFERS THE PROLACTIN RESPONSE (VOL 13, PG 2182, 1994)

      EMBO journal
    81. PALLARD C; GOUILLEUX F; BENIT L; COCAULT L; SOUYRI M; LEVY D; GRONER B; GISSELBRECHT S; DUSANTERFOURT I
      THROMBOPOIETIN ACTIVATES A STAT5-LIKE FACTOR IN HEMATOPOIETIC-CELLS

      EMBO journal
    82. LIU XW; ROBINSON GW; GOUILLEUX F; GRONER B; HENNIGHAUSEN L
      CLONING AND EXPRESSION OF STAT5 AND AN ADDITIONAL HOMOLOG (STAT5B) INVOLVED IN PROLACTIN SIGNAL-TRANSDUCTION IN MOUSE MAMMARY TISSUE

      Proceedings of the National Academy of Sciences of the United Statesof America
    83. GAFFEN SL; LAI SY; XU WD; GOUILLEUX F; GRONER B; GOLDSMITH MA; GREENE WC
      SIGNALING THROUGH THE INTERLEUKIN-2 RECEPTOR-BETA CHAIN ACTIVATES A STAT-5-LIKE DNA-BINDING ACTIVITY

      Proceedings of the National Academy of Sciences of the United Statesof America
    84. FUJII H; NAKAGAWA Y; SCHINDLER U; KAWAHARA A; MORI H; GOUILLEUX F; GRONER B; IHLE JN; MINAMI Y; MIYAZAKI T; TANIGUCHI T
      ACTIVATION OF STAT5 BY INTERLEUKIN-2 REQUIRES A CARBOXYL-TERMINAL REGION OF THE INTERLEUKIN-2 RECEPTOR-BETA CHAIN BUT IS NOT ESSENTIAL FOR THE PROLIFERATIVE SIGNAL TRANSMISSION

      Proceedings of the National Academy of Sciences of the United Statesof America
    85. PALLARD C; GOUILLEUX F; CHARON M; GRONER B; GISSELBRECHT S; DUSANTERFOURT I
      INTERLEUKIN-3, ERYTHROPOIETIN, AND PROLACTIN ACTIVATE A STAT5-LIKE FACTOR IN LYMPHOID-CELLS

      The Journal of biological chemistry
    86. WOOD TJJ; SLIVA D; LOBIE PE; PIRCHER TJ; GOUILLEUX F; WAKAO H; GUSTAFSSON JA; GRONER B; NORSTEDT G; HALDOSEN LA
      MEDIATION OF GROWTH HORMONE-DEPENDENT TRANSCRIPTIONAL ACTIVATION BY MAMMARY-GLAND FACTOR STAT-5

      The Journal of biological chemistry
    87. JESCHKE M; WELS W; DENGLER W; IMBER R; STOCKLIN E; GRONER B
      TARGETED INHIBITION OF TUMOR-CELL GROWTH BY RECOMBINANT HEREGULIN-TOXIN FUSION PROTEINS

      International journal of cancer
    88. WELS W; BEERLI R; HELLMANN P; SCHMIDT M; MARTE BM; KORNILOVA ES; HEKELE A; MENDELSOHN J; GRONER B; HYNES NE
      EGF RECEPTOR AND P185(ERB-2)-SPECIFIC SINGLE-CHAIN ANTIBODY TOXINS DIFFER IN THEIR CELL-KILLING ACTIVITY ON TUMOR-CELLS EXPRESSING BOTH RECEPTOR PROTEINS

      International journal of cancer
    89. BARAHMANDPOUR F; MEINKE A; EILERS A; GOUILLEUX F; GRONER B; DECKER T
      COLONY-STIMULATING FACTORS AND INTERFERON-GAMMA ACTIVATE A PROTEIN RELATED TO MGF-STAT-5 TO CAUSE FORMATION OF THE DIFFERENTIATION-INDUCED FACTOR IN MYELOID CELLS

      FEBS letters
    90. GOUILLEUX F; MORITZ D; HUMAR M; MORIGGL R; BERCHTOLD S; GRONER B
      PROLACTIN AND INTERLEUKIN-2 RECEPTORS IN T-LYMPHOCYTES SIGNAL THROUGHA MGF-STAT5-LIKE TRANSCRIPTION FACTOR

      Endocrinology
    91. GOBERT S; CHRETIEN S; GOUILLEUX F; MULLER O; PALLARD C; DUSANTERFOURT I; GRONER B; LACOMBE C; GISSELBRECHT S; MAYEUX P
      IDENTIFICATION OF TYROSINE RESIDUES WITHIN THE INTRACELLULAR DOMAIN OF THE ERYTHROPOIETIN RECEPTOR CRUCIAL FOR STAT5 ACTIVATION

      Blood
    92. STANDKE GJR; MEIER VS; GRONER B
      MAMMARY-GLAND FACTOR-ACTIVATED BY PROLACTIN IN MAMMARY EPITHELIAL-CELLS AND ACUTE-PHASE RESPONSE FACTOR-ACTIVATED BY INTERLEUKIN-6 IN LIVER-CELLS SHARE DNA-BINDING AND TRANSACTIVATION POTENTIAL

      Molecular endocrinology
    93. HYNES NE; MARTE BM; HELLMANN P; BEERLI R; GRONER B; WELS W
      RECOMBINANT SINGLE-CHAIN IMMUNOTOXINS SPECIFIC FOR EGF AND ERBB-2 RECEPTORS INHIBIT IN-VIVO AND IN-VITRO TUMOR-CELL GROWTH

      Journal of cellular biochemistry
    94. MESSERLE K; SCHLEGEL J; HYNES NE; GRONER B
      NIH 3T3 CELLS TRANSFORMED WITH THE ACTIVATED ERBB-2 ONCOGENE CAN BE PHENOTYPICALLY REVERTED BY A KINASE DEFICIENT, DOMINANT-NEGATIVE ERBB-2VARIANT/

      Molecular and cellular endocrinology
    95. GRONER B; ALTIOK S; MEIER V
      HORMONAL-REGULATION OF TRANSCRIPTION FACTOR ACTIVITY IN MAMMARY EPITHELIAL-CELLS

      Molecular and cellular endocrinology
    96. ALTIOK S; GRONER B
      BETA-CASEIN MESSENGER-RNA SEQUESTERS A SINGLE-STRANDED NUCLEIC ACID-BINDING PROTEIN WHICH NEGATIVELY REGULATES THE BETA-CASEIN GENE PROMOTER

      Molecular and cellular biology
    97. MEIER VS; GRONER B
      THE NUCLEAR FACTOR-YY1 PARTICIPATES IN REPRESSION OF THE BETA-CASEIN GENE PROMOTER IN MAMMARY EPITHELIAL-CELLS AND IS COUNTERACTED BY MAMMARY-GLAND FACTOR DURING LACTOGENIC HORMONE INDUCTION

      Molecular and cellular biology
    98. WAKAO H; GOUILLEUX F; GRONER B
      MAMMARY-GLAND FACTOR (MGF) IS A NOVEL MEMBER OF THE CYTOKINE REGULATED TRANSCRIPTION FACTOR GENE FAMILY AND CONFERS THE PROLACTIN RESPONSE

      EMBO journal
    99. GOUILLEUX F; WAKAO H; MUNDT M; GRONER B
      PROLACTIN INDUCES PHOSPHORYLATION OF TYR694 OF STAT5 (MGF), A PREREQUISITE FOR DNA-BINDING AND INDUCTION OF TRANSCRIPTION

      EMBO journal
    100. MORITZ D; WELS W; MATTERN J; GRONER B
      CYTOTOXIC T-LYMPHOCYTES WITH A GRAFTED RECOGNITION SPECIFICITY FOR ERBB2-EXPRESSING TUMOR-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/08/20 alle ore 16:41:46